Molecular genetic study on HAND2 gene promoter in ventricular septal defect

Ventricular septal defect (VSD), as the most common type of congenital heart disease (CHD), is mainly caused by cardiac dysplasia. Heart and neural crest derivatives expressed 2 (HAND2), as a member of the basic helix-loop-Helix (bHLH) gene family, participates in the development of the right heart. And the loss of HAND2 expression in humans is closely connected with ventricular septal defects. However, no studies have hitherto examined the association between VSD and HAND2 gene promoter. We used a case-control study to analyze the genetic variations of the HAND2 gene promoter region in VSD patients and controls. Using a variety of statistical analysis methods to analyze the association of single nucleotide polymorphisms (SNPs) with VSD. The dual luciferase reporter assay was used to conduct functional analysis of genetic variations. Electrophoretic mobility shift assay (EMSA) was used to examine DNA-protein interactions. Through sequencing, we identified nine genetic variants in patients with VSD. The SNP rs2276940 G>T and rs2276941 G>A were revealed to have associations with an increased risk of VSD. The dual luciferase reporter assay showed that the SNP rs2276940 G>T and rs138531627 C>G decreased the transcriptional activity of the HADN2 gene promoter. Transcription factors (TFs) predicting suggested that all three above SNPs may change the binding of the TFs. The result of EMSA showed that rs138531627 C>G may create a new binding site for TFs while rs2276940 G>T enhanced the binding affinity for TFs. All these results indicated that genetic variants of the HAND2 gene promoter increase VSD risk by reducing HAND2 expression, and the molecular mechanism may be the change of the binding affinity of TFs.


46
To date, congenital heart defect (CHD) is still the most common congenital anomaly, common type of congenital heart disease [5]. The same as other types of congenital heart 52 defect, the major pathogenesis of ventricular septal defect is cardiac dysplasia [6]. 53 The development of the heart, the earliest functional organ formed in the mammalian 54 embryo, requires the precisely control of transcriptional regulation networks and cell 55 signaling pathways [7,8]. During embryonic heart development, cardiac progenitor cells in 56 the mesoderm differentiate into the first heart field and the second heart field, in which the 57 first heart field forms the left ventricle and the left and right atrium, and the second heart 58 field forms the right ventricle, outflow tract and part of the atrium [9]. Multiple cardiac 59 transcription factors (TFs) such as GATA binding protein (GATA)[10], heart and neural 60 crest derivatives expressed (HAND) [11], NK2 homeobox 5 (Nkx2-5) [12], and the T-box . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 28, 2022. ; https://doi.org/10.1101/2022.06.28.22277011 doi: medRxiv preprint 4 61 family members [13] play critical roles in this process. As a matter of course, mutations in 62 these TFs will contribute to cardiac dysplasia, as well as lead to VSD [14]. 63 The HAND gene, as a member of the basic helix-loop-Helix (bHLH) gene family, is 64 highly conserved [15]. It has two isoforms that are asymmetrically expressed in developing 65 ventricular chambers, namely HAND1 and HAND2. Before the formation of the heart tube, . Further experiment confirms that loss of HAND2 in the second heart field 74 will enhance apoptosis of cardiac progenitor cells before they take part in the process of 75 heart development, contributing to serious hypoplasia of the right ventricle [19]. 76 Simultaneously, an increasing body of evidence suggests that abnormal expression of 77 HAND2 in humans is closely connected with congenital heart defect that include 78 ventricular septal defects [20,21], despite recent study suggesting that HAND2 is a specific 79 factor for outflow tract cells rather than right ventricular cells [22]. 80 Based on the above studies, we consider that the loss of HAND2 expression is one of . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 28, 2022.

Sequence analysis
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

119
HAND2 gene promoter activity was showed as the ratio of luciferase activity over Renilla 120 luciferase activity. Empty vector pGL3-basic was used as a negative control. The . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 28, 2022. ; https://doi.org/10.1101/2022.06.28.22277011 doi: medRxiv preprint 121 transcription activity of the wild-type HAND2 gene promoter was set as 100%. All the 122 experiments were repeated three times independently, in triplicate.

Isolation of primary neonatal rat cardiomyocytes (NRCMs)
124 Two SPF-grade SD rats, purchased from Jinan Pengyue Experimental Animal 125 Breeding Co., LTD., the license number is SCXK (Lu) 2019-0003. Neonatal rat pups (1-3 126 days old, gender unknown) from the mother were disinfected with 75% alcohol before 127 removing their hearts. The extracted heart was put into PBS containing 100 U/mL 128 penicillin streptomycin to remove non cardiac tissue and residual blood, and then cut the 129 heart into pieces. The chopped tissue was digested with 0.25% trypsin for 5 minutes, and  The protein concentration of the nuclear extract was measured using Bio-Rad Protein . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. over-dominant, recessive, and log-additive) and VSD, and the results were showed as odds 155 ratio (OR) and 95% confidence interval (CI). P < 0.05 was considered as statistically 156 significant.

158
Nine genetic variants were identified in patients with VSD 159 A total of twelve genetic variants were identified in the promoter of HAND2, through 160 sequencing in 349 VSD patients and 345 healthy control subjects (Fig 1). The VSD patients . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

165
Nine genetic variants, including eight single nucleotide polymorphisms (SNPs), were 166 identified in patients with VSD (Fig 2A) and another three were present only in controls 167 ( Fig 2B). The chi-square test showed that the distribution of g.173530848 G>T (rs2276940) 168 and g.173530503 G>A (rs2276941) in VSD patients and healthy control subjects are 169 statistically significant (Table 1). The Online website SNPStats was used to analyse the 170 correlations between multiple genetic models of the above two SNPs and AMI. The  ( Table 3).

promoter region and VSD (adjusted by SEX + AGE).
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 28, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 28, 2022.  gene promoter (Fig 3).
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.   . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 28, 2022. for TFs only in HEK293 cells (Fig 4). . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 28, 2022. TFs. Then we explored the molecular mechanism by conducting EMSA for these SNPs.

278
The results showed that rs138531627 C>G created a new binding site for TFs in both 279 HEK293 and NRCMs cells, while rs2276940 G>T enhanced the binding affinity for TFs 280 only in HEK293 cells. Therefore, we speculated that the reduced transcriptional activity of 281 HAND2 promoter caused by rs138531627 C>G and rs2276940 G>T may be due to the 282 changes in TFs binding. However, since there is no commercial EMSA antibody, we did 283 not further verify the binding of TFs and these SNPs.

284
In summary, we found three SNPs that are helpful in identifying the genetic causes of 285 VSD and conducted functional analysis and molecular mechanism study on them. These 286 conclusions have certain reference significance for exploring the molecular genetic 287 mechanism of VSD and clarifying the regulatory network of HAND2. However, we still 288 need to expand the sample size and in-depth mechanism research to further verify this 289 conclusion and clarify the relevant molecular mechanism.
290 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.    . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.